Genetically fused antigenic protein domain with a scaffolding polypeptide that self assembles into soluble oligomeric nanoparticles that comprise at least six copies of the antigen protein domain. Specifically, DNA plasmid encoding protein antigen domains of the viral Spike protein of SARS-CoV-2 genetically fused to the scaffolding polypeptide is used as a vaccine against Covid-19.
F.32 International patent
COBISS.SI-ID: 43483395